Delving deeper into the effects of FSP1 inhibition on the biological characteristics of HNSCC-DTP cells, including their stemness, invasive capacity, and metastatic potential, we employed immunoblotting techniques. The gene discussed is AIFM2; the disease is head and neck squamous cell carcinoma.